gsk defence is in todays fin review,they seem to be contradicting themselves by saying sales were weak due to inhaler,BUT,the inhaler is great in 2001,and that they admit to under funding on promotion, pay up gsk while your still out of court,or else biota will be front page news when bird flu hits,e.g GSK HIDES RELENZA FROM THOSE MOST IN NEED.............................